EDGAR Filing Documents for 0001193125-08-108316

Form 8-K - Current report:

SEC Accession No. 0001193125-08-108316

Filing Date

2008-05-09

Accepted

2008-05-08 21:15:05

Documents

Period of Report

2008-05-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	28277
2	WAIVER AND AMENDMENT AGREEMENT	dex43c.htm	EX-4.3C	43266
3	WARRANT ISSUED TO KINGSBRIDGE CAPITAL LIMITED	dex46a.htm	EX-4.6A	53654
4	REGISTRATION RIGHTS AGREEMENT	dex46b.htm	EX-4.6B	53301
5	COMMON STOCK PURCHASE AGREEMENT	dex1070.htm	EX-10.70	195786
6	JAZZ PHARMACEUTICALS CODE OF CONDUCT	dex141.htm	EX-14.1	122028
7	GRAPHIC	g83414img001.jpg	GRAPHIC	23190
	Complete submission text file	0001193125-08-108316.txt		530143

Mailing Address 3180 PORTER DRIVE PALO ALTO CA 94304

Business Address 3180 PORTER DRIVE PALO ALTO CA 94304 650-496-3777

JAZZ PHARMACEUTICALS INC (Filer) CIK: 0001232524 (see all company filings)